GlassScriptPhysician profile
Amon Zakeri
NPI 1790205920
$3,037.88
in general payments reported to CMS, 2019-2025
12 companies · $990 in 2025
The $990 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.24 · 2023: $239 · 2024: $1,793 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,661 · Travel and Lodging: $1,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,661.23 |
| Travel and Lodging | $1,361.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,025.40 | 2023-2025 | Pipeline, Axium Primetm, Solitaire X |
| Penumbra, INC. | $302.79 | 2025 | Red 72, Smart Coil, Penumbra Coil 400 |
| Imperative Care, INC | $178.71 | 2025 | Zoom 88-T Large Distal Platform, Zoom 7x Catheter |
| Stryker Corporation | $146.80 | 2023-2025 | Trevo, Target, Axs Vecta 71 |
| Scientia Vascular | $133.97 | 2025 | Aristotle |
| Providence Medical Technology, INC. | $86.92 | 2025 | |
| Zimmer Biomet Holdings, INC. | $48.65 | 2025 | Iq Devices/Batteries, Neuro Plating System |
| Route 92 Medical, INC. | $37.85 | 2025 | |
| Asahi Intecc USA, INC. | $23.61 | 2024 | Peripheral Vascular |
| Cardiva Medical, INC. | $20.39 | 2025 | Cardiva Vascade 6/7f Vcs |
| Solventum Corporation | $17.55 | 2025 | V.A.C. Granufoam, Prevena |
| Irras USA, INC. | $15.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amon Zakeri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.